"Treatment Of Scleroderma" in Patent Application Approval Process (USPTO 20240358692).

MLA

“‘Treatment Of Scleroderma’ in Patent Application Approval Process (USPTO 20240358692).” Drug Week, Nov. 2024, p. 3240. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891539&authtype=sso&custid=ns315887.

APA

“Treatment Of Scleroderma” in Patent Application Approval Process (USPTO 20240358692). (2024). Drug Week, 3240.

Chicago

“‘Treatment Of Scleroderma’ in Patent Application Approval Process (USPTO 20240358692).” 2024. Drug Week, November, 3240. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=180891539&authtype=sso&custid=ns315887.